Foothill Ranch, CA (PRWeb) December 5, 2006 -- The orthopedic biomaterials market is an evolving arena in the development, adoption and/or evolving use of bone, bone substitutes, polymers, ceramics, bone growth factors, sealants/glues, anti-adhesion, tissue engineering and other products. The market is party to established orthopedic device manufacturers as well as niche biomaterials companies with innovative offerings. The resulting $5 billion current orthopedic biomaterials market will grow at double digit annual rates reaching nearly $10 billion by 2011. MedMarket Diligence has completed a global report on products, technologies, markets and players, with insights on the market's outlook.

Orthopedic biomaterials encompass a range of materials that dynamically interact with orthopedic tissues in order to enhance the healing process associated with trauma, disease and/or surgery. These therefore include allograft, bone substitutes, polymers, ceramics, bone growth factors, sealants/glues, anti-adhesion, tissue engineering and other products. Their use in orthopedic practice is robust owing to a combination of established procedures in hip and knee surgery, spine surgery, fracture repair and other orthopedic applications and proven clinical results of biomaterials in enhancing repair/healing.

Competition in the market for biomaterials includes established orthopedic device players like Stryker, De Puy, Interpore Cross, and Smith & Nephew, but also includes a range of focused biomaterials innovators from Genzyme BioSurgery to considerably smaller players.

The MedMarket Diligence report on the global orthopedic biomaterials market details the products and technologies on the market and under development and the current and forecast market for these materials in the U.S., Europe, Japan and the Rest of World. The report's coverage and full table of contents are shown at http://www.mediligence.com/rpt/rpt-m625.htm. For additional details, contact Patrick Driscoll at 949-859-3401 or patrick-at-mediligence-dot-com.

About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, and dedicated reports on technology markets.